NCT06311162

Brief Summary

Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
May 2024Dec 2028

First Submitted

Initial submission to the registry

March 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 7, 2024

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2028

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

3.7 years

First QC Date

March 7, 2024

Last Update Submit

April 30, 2026

Conditions

Keywords

Secondhand smokeChildrenPreventioneHealth

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in urinary levels of cotinine in children

    Change in exposure to second-hand smoke exposure assessed by urinary levels of cotinine

    At 22 weeks after baseline (Post intervention)

  • Change from baseline in urinary levels of cotinine in children

    Change in exposure to second-hand smoke exposure assessed by urinary levels of cotinine

    At 48 weeks after baseline (Follow-Up)

Secondary Outcomes (1)

  • Change from baseline in protective measures taken by parents to protect children from second-hand smoke exposure

    During intervention (week 2-22), post intervention (week 22-23) and follow-up (week 48-49)

Other Outcomes (8)

  • Acceptance and usability of the app (parent reported outcome)

    At 22 weeks after baseline (Post intervention)

  • Acceptance of the app

    During the intervention (week 2-22)

  • Usability of the app

    During the intervention (week 2-22)

  • +5 more other outcomes

Study Arms (2)

Treatment group (Life-style app)

EXPERIMENTAL

Parents receive a smartphone app during the main intervention period of 20 weeks. The app (life-style app) aims to promote healthy behaviour through cognitive-behavioural impact factors.

Behavioral: Life-Style app

Control group

SHAM COMPARATOR

The parents get an information sheet with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.

Other: Sham Comparator

Interventions

Life-Style appBEHAVIORAL

The modules of the Life-Style app are introduced and unlocked sequentially during the first weeks of the intervention phase. Afterwards the modules are fully available. Duration and frequency of app-use is not limited. The parents are accompanied by a coach through the app, who gives regular structured feedback and individual inputs. The coach has access to all data collected in the app.

Also known as: Smartphone App
Treatment group (Life-style app)

The parents get a flyer with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.

Also known as: Flyer about second-hand smoke exposure
Control group

Eligibility Criteria

AgeUp to 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age: younger than 6 years
  • Exposed to second-hand smoke at home (at least one parent smoking)
  • German speaking parent
  • All sex and ethnic backgrounds
  • Signed informed consent form from parent
  • Children live/grow-up in the same household as the parental participant
  • Referred by a health care professional (e.g. physician, midwife, nurse, other professions)

You may not qualify if:

  • Participation in another study/trial targeting similar outcomes
  • Participation in an active smoking cessation programme

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Paediatrics, Inselspital, Bern University Hospital

Bern, 3010, Switzerland

RECRUITING

Related Publications (1)

  • Koch A, Wyssen A, Haupt C, Hammelbeck J, van Dorland HA, Fluck CE, Latzin P, Saner C, Jakob J, Kaess M, Kopp MV. Early Life Intervention in Paediatrics Supported by E-Health (ELIPSE)-a coaching app for parents to reduce obesity and second-hand smoke exposure in children: study protocols for two parallel-group randomised controlled trials. Trials. 2025 Nov 18;26(1):520. doi: 10.1186/s13063-025-09251-5.

MeSH Terms

Conditions

Smoking ReductionRespiratory SoundsNoncommunicable DiseasesSmoking

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Study Officials

  • Matthias V. Kopp, Prof. Dr.

    Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Switzerland

    PRINCIPAL INVESTIGATOR
  • Michael Kaess, Prof. Dr.

    Universitäre Psychiatrische Dienste Bern (UPD), University of Bern, Switzerland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Matthias V. Kopp, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
The study team members who are conducting assessments on the participants remain blinded to the treatment allocation.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Single-blind randomized controlled parallel-group clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2024

First Posted

March 15, 2024

Study Start

May 7, 2024

Primary Completion (Estimated)

January 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

May 6, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations